SCHEMBL18838508

SCHEMBL18838508

CC(C)(C)OC(=O)N1CCC2(CCCC2)C(NCc2ccccc2)C1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.46
▸ KEAP1 Q14145 1/20 0.45
▸ NFE2L2 Q16236 1/20 0.45
▸ JAK2 O60674 1/20 0.45
▸ JAK1 P23458 1/20 0.45
▸ GPR119 Q8TDV5 1/20 0.45
▸ KDM1A O60341 2/20 0.44
▸ STS P08842 1/20 0.44
▸ USP30 Q70CQ3 2/20 0.44
▸ ACHE P22303 1/20 0.44
▸ OPRD1 P41143 1/20 0.43
▸ OPRK1 P41145 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ TACR1 P25103 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18838380 0.98 NAMPT (0.46) NAMPTKEAP1NFE2L2JAK2JAK1
SCHEMBL18838507 0.89 KEAP1 (0.49) NAMPTKEAP1NFE2L2GPR119KDM1A
SCHEMBL16914195 0.89 LMNA (0.48) NAMPTGPR119STSLMNA
SCHEMBL18838379 0.87 STS (0.51) NAMPTKEAP1NFE2L2GPR119KDM1A
SCHEMBL15601289 0.84 KEAP1 (0.46) NAMPTKEAP1NFE2L2JAK2JAK1
SCHEMBL18838335 0.82 USP30 (0.53) NAMPTGPR119KDM1AUSP30KDM4E
SCHEMBL30989041 0.81 NPFFR1 (0.49) NAMPTJAK2JAK1GPR119STS
Trifluoroacetic Acid SCHEMBL15577382 0.80 KEAP1 (0.42) NAMPTKEAP1NFE2L2GPR119KDM1A
SCHEMBL16914492 0.79 ALDH1A1 (0.44) GPR119STSLMNA
SCHEMBL16914194 0.78 ALDH1A1 (0.51) NAMPTGPR119STSLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3340988-A1 ION CHANNEL INHIBITORY COMPOUNDS, PHARMACEUTICAL FORMULATIONS AND USES Afasci, Inc. (US) 2018-07-04 — — EP disclosed
WO-2017083867-A1 ION CHANNEL INHIBITORY COMPOUNDS, PHARMACEUTICAL FORMULATIONS AND USES AFASCI, INC. (US) 2017-05-18 — — WO disclosed
Send feedback